China's Rise in Global Clinical Trials: Regulatory Reforms and US Competitiveness
By
Pocket Casts
Summary
Theo Jaffee and Gabriel Dickinson interview Cremieux about China's rapid ascent to global leadership in clinical trial output. The discussion covers China's regulatory reforms that accelerated its progress, the surge in novel drug development, and what the US would need to change to remain competitive in biomedical innovation.
Source
Twitter / XChina's Rise in Global Clinical Trials: Regulatory Reforms and US Competitivenesspocketcasts.comKey quotes
· 3 pulledChina's rapid rise to the top of global clinical trial output has been accelerated by significant regulatory reforms.
The surge in novel drug development in China represents a major shift in the global biomedical landscape.
The US would need to change several factors to stay competitive in biomedical innovation.
You might also wanna read
China's biotech rise: A case study in multiple myeloma drug development
This article examines China's rapid advancement in biotechnology through the lens of a multiple myeloma drug development case study. It disc
writingruxandrabio.com·10h ago
China creates new regulatory pathway to accelerate access to advanced biomedical therapies
China has established a new regulatory "tech track" for advanced therapies like personalized cancer treatments, cell and gene therapies, and
biopharmadive.com·8d agoTraitements contre le cancer : «La Chine est en train de devenir le leader mondial du médicament»
US-China Tech Competition: A Strategic Playbook for Long-Term Leadership
The article presents a nuanced analysis of the US-China technology competition, arguing that neither nation is as dominant or as weak as com
csis.org·2d ago
U.S. restrictions on Chinese biotechnology could harm patients, argues editorial
The article argues against U.S. efforts to restrict collaboration with China's biotechnology industry, framing it as an extension of the tec
econ.st·3d ago
China's healthcare sector faces higher barriers than EVs in global innovation push
China's healthcare sector is emerging as a potential new frontier for innovation and globalization, following the success of its electric ve
weforum.org·1d agoComments
Sign in to join the conversation.
No comments yet. Be the first.